4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-057556
Chief Scientific Officer sold 3,000 shares at an average $69.69 ($209,071)
- Chief Scientific Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2018-11-05 | Option exercise | +3,000 | $9.05 | $27,150 | 53,932 | D |
| Biller Scott Chief Scientific Officer | 2018-11-05 | Sale | −2,200 | $69.44 | $152,768 | 51,732 | D |
| Biller Scott Chief Scientific Officer | 2018-11-05 | Sale | −700 | $70.23 | $49,161 | 51,032 | D |
| Biller Scott Chief Scientific Officer | 2018-11-05 | Sale | −100 | $71.42 | $7,142 | 50,932 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2018-11-05 | Option exercise · Stock options (right to buy) | −3,000 | 4,154 | D | ||
| Open-market sales · 3,000 sh · avg $69.69 · $209,071 | |||||||
Loading xslF345X03/doc4.xml…